PFE Pfizer Inc.
Research report · from SEC EDGAR · close 2026-07-15
$24.82 +2.4%
$141.46B mkt cap
executive summary
Pfizer Inc. (PFE) is a $141.46B company. Revenue is $62.58B (-1.6% y/y) at a 12% net margin. It is profitable. Our health score is C (64/100). No major red flags on file. Held by 2 tracked funds. It funds itself; low dilution risk.
Revenue (FY)
$62.58B
-1.6% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 1
Cash & ST investments
$1.70B
Operating cash flow
$11.70B
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-15 by stocktools.ai.